Huisong Pharmaceuticals has completed the development of the group standard “Technical Regulation for the Purification of Bioactive Components in Homology of Medicine and Food Materials.”

Huisong Pharmaceuticals has completed the development of the group standard “Technical Regulation for the Purification of Bioactive Components in Homology of Medicine and Food Materials.”
In August 2025, Huisong Pharmaceuticals completed the development of the group standard “Technical Regulation for the Purification of Bioactive Components in Homology of Medicine and Food Materials” (T/CIET 1640—2025). Led by China Association for Promoting International Economic & Technical Cooperation, and jointly developed with research institutes, testing organizations, and Huisong Pharmaceuticals, this marks an important milestone in the standardization of the homology of medicine and food industry.
This standard focuses on the purification processes of key bioactive components such as alkaloids, flavonoids, saponins, and polysaccharides, and sets forth systematic requirements covering process flow, technical specifications, quality control, and testing methods. Its establishment and implementation are expected to address long-standing challenges of inconsistent purification practices and unstable quality across the industry, providing highly practical technical guidance for the entire supply chain.
Beyond improving the stability and traceability of active ingredients, this standard will also provide strong support for the development of functional foods, dietary supplements, and innovative traditional Chinese medicine (TCM). With the rollout of this standard, the homology of medicine and food industry is poised to take a solid step toward greater standardization, industrialization, and internationalization.